Contemporary insights into cancer. Risks, perspectives, expectations Lunch Mechanisms of tumor growth and differentiation
|
|
- Grace Cooper
- 7 years ago
- Views:
Transcription
1 Contemporary insights into cancer. Risks, perspectives, expectations Saturday, Feb 16 th Lunch Mechanisms of tumor growth and differentiation Prof. Alicja Józkowicz Role of micrornas in tumor growth and differentiation Agata Szade Role of heme oxygenase-1 in squamous cell carcinoma Maciej Ciesla Novel therapies of rhabdomyosarcoma Jacek Stępniewski Teratoma formation as the model for pluripotency of stem cells Coffee break and poster viewing Angiogenesis and anti-angiogenic therapies Dr Agnieszka Łoboda Hypoxia-driven tumor vascularisation Dr Agnieszka Jaźwa Regulatable vectors for pro-and anti-angiogenic therapies Prof. Józef Dulak micrornas in tumor angiogensis: tools and targets Anna Grochot-Przeczek Proangiogenic progenitor cells Krzysztof Szade In vivo imaging of angiogenesis and tumor growth: novel models Witold Nowak New approaches to treatment of leukemias Urszula Florczyk Role of Nrf2 in tumor angiogenesis Magdalena Kozakowska Acellular proangiogenic therapies Welcome party and reminiscences
2 Sunday, Feb 17 th Targeted therapies Inaugural lecture: Prof. Tomasz Grodzicki Dark side of the moon - consequences of curing cancer Prof. Hanna Rokita Anti-GD2 ganglioside strategy in treatment of neuroblastoma Dr Irena Horwacik Application of molecular mimicry to target GD2 ganglioside Durbas Małgorzata A role of aurora A kinase and its substrates in 14G2a monoclonal antibody toxicity against human neuroblastoma Prof. Grzegorz Bartosz Multidrug transporters and their role in the failure of cancer chemotherapy Anti-cancer molecular biology strategies Dr Dominika Nowis Influence of statins on glucose uptake by human cells Prof. Claudine Kieda Angiogenesis normalization strategies: molecular mechanism in tumor therapy Prof. Joanna Bereta Genetically-modified Salmonella - a new option in cancer therapy? Maria Czarnek Role of ADAM17 in a murine model of colon carcinoma Dr Monika Bzowska Poster session I Tumor-targeting with monoclonal antibodies
3 Monday, Feb 18 th First premedical aid training (in Polish) Marcin Zawrotniak Poster session II Radiotherapy of cancer Prof. Howard Halpern Application of EPR O 2 Imaging to Radiation Biology and Therapy Prof. Bożena Romanowska-Dixon A new treatment modality of intraocular neoplasm - proton radiotherapy in Kraków Prof. Paweł Olko New opportunities for tumor therapy using proton beam Dr Martyna Elas DNA damage, protein expression and migration of melanoma cells irradiated with proton beam Phototherapy of cancer Dr Janusz Dąbrowski "Luz11 - a novel photosensitizer for photodynamic therapy on its way from synthesis to clinical trials Martyna Krzykawska F 2 Bmet-PDT effects on vasculature Dr Jolanta Saczko Photodynamic therapy and its modification in cancer cells Monika Jakubowska Double-faced roles of nitric oxide in photodynamic therapy of cancer: our friend or enemy Anita Burkat-Dulak, Justyna Morawska-Płoskonka Delivering innovation in life science branch Student s Science Club
4 Tuesday, Feb 19 th Immunotherapy of cancer Prof. Chantal Pichon RNA-based vaccines Prof. Richard Daniellou "Immunostimulating glycans in cancer Dr Mateusz Kwitniewski DNA methylation and cancer immunotherapy Aleksandra Pęcak Aptamer based approach to target p53-mdm2 interaction in cancer Novel ideas of anti-cancer therapy Prof. Andrzej Mackiewicz Immunotargeting human melanoma stem cells with Hyper-IL-6 gene modified whole cell vaccine Łukasz Kalinowski, Dr Jerzy Pieczykolan From scientific concept to preclinical evaluation - 3CLA - targeted anticancer therapy Justyna Supel Malopolska Centre of Biotechnology Dr Tomasz Rzymski Conference dinner Perspectives on Development of Novel Classes of Cyclin Dependent Kinase Inhibitors as Anticancer Drugs
5 Wednesday, Feb 20 th Skiing competition Novel ideas of anti-cancer therapy Maja Swoboda, Dr Arkadiusz Miciałkiewicz NEXT GENeration SCIENCE - from the sequence to the change. The story how Life Technologies is improving genome research providing tools for genetic engineering. The easy way to advanced regenerative medicine Prof. Alicja Ratuszna A new perspective for the education and science in the modern labs in Silesian Center of Education and Interdisciplinary Research Michał Sarna Nanomechanical analysis of melanoma cells 16: Coffee break and poster viewing Carcinogenesis and tumor development Prof. Tadeusz Sarna Are Transition Metal the Missing Risk Factors for Cutaneous Malignant Melanoma? Prof. Ewa Sikora Therapy induced senescence - hope or hype? Dr Maja Grabacka Targeting tumor cell metabolism as an alternative therapeutic perspective" Dr Agnieszka Wolnicka-Głubisz UV-induced melanoma in HGF/SF transgenic mouse Debate: Introducing new therapies into clinic
CURRICULUM OVERVIEW - 3-YEAR PHYSIOTHERAPY PROGRAM. Pass/fail /Examination Prof. Małgorzata Bruska, MD, PhD. Hours (total)
CURRICULUM OVERVIEW - 3-YEAR PROGRAM FIRST YEAR Course Course coordinator Name of Chair/Department GROSS ANATOMY PHYSIOLOGY MEDICAL BIOLOGY BIOCHEMISTRY BIOPHYSICS PHILOSOPHY SOCIOLOGY ETHICS AND DEONTOLOGY
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More informationSession I From biochemistry to biotechnology, part I BEL-AMI Hotel Conference Room Chair: Joanna Bereta
PROGRAMME TUESDAY, 16 FEBRUARY 2016 10:30 Departure from Kraków Faculty of Biochemistry, Biophysics and Biotechnology, 7 Gronostajowa St., 30-387 Krakow 12:00-13:00 Registration 14:05-14:15 Opening of
More informationReport on twinning short visit within the WP1 Task 1.11 of BASTION project
Report on twinning short visit within the WP1 Task 1.11 of BASTION project Science Business, 16-18 Feb 2015, Brussels Karolina Dzwonek Jakub Golab Jakub Golab, BASTION project coordinator and Karolina
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationtreatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can
Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods
More informationThe Agenda of 2nd International Scientific Conference. Epimilitaris 2013 Bioterrorism
The Agenda of 2nd International Scientific Conference Epimilitaris 2013 Bioterrorism 09.09.2013 Day 1 13.00-14.30 Registration of the conference participants Opening session Host: Ryan Madden, Zbigniew
More information1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet
More informationConference opening 11.15 13.15. Strona 1 z 5
THE SCIENTIFIC CONFERENCE TO CELEBRATE THE INTERNATIONAL YEAR OF STATISTICS ŁÓDŹ 17-18 October 2013 STATISTICS KNOWLEDGE DEVELOPMENT 17 October 2013 9.00 9.15 Conference opening Statistics in the face
More informationSCHEDULE - FALL 2013/14
Economics, International Relations and Social Sciences (); Finance, Accounting and Banking (F,A&B); Informatics (Computer Science), Quantitative Methods and Technology (I,MM&T); Management Sciencs ();
More informationCURRICULUM OVERVIEW - 5-YEAR DDS PROGRAM. /Examination (total) GROSS ANATOMY Prof. Małgorzata Bruska, Chair and Department of
CURRICULUM OVERVIEW - 5-YEAR DDS PROGRAM FIRST YEAR Course Course coordinator Chair/Department GROSS ANATOMY Prof. Małgorzata Bruska, 150 50 100 0 11 Examination MD, Anatomy BIOPHYSICS Marek Tuliszka,
More informationJavier Fombona / FACULTAD DE Formación del Profesorado y Educación (Univ. Oviedo) Información OFERTA ESTUDIOS EN POLONIA LUBLIN
Información OFERTA ESTUDIOS EN POLONIA LUBLIN Course Subject area Form of the class Name of the academic teacher Semester Type of An introduction to human biopsychological development across the life span
More informationBiochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!!
Biochemistry Major Talk 2014-15 August 14, 2015 Department of Biochemistry The University of Hong Kong Welcome!!!!!!!!!!!!!! Introduction to Biochemistry A four-minute video: http://www.youtube.com/watch?v=tpbamzq_pue&l
More informationAbstracts of the VIII Parnas Conference. Warsaw, Poland August 27 31, 2011
Abstracts of the VIII Parnas Conference Warsaw, Poland August 27 31, 2011 Patronage: Minister of Foreign Affairs Mr. Radoslaw Sikorski Minister of Science and Higher Education Prof. Barbara Kudrycka Honorary
More informationSummary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs
Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer
More informationTuesday 22.09.2015 CONFERENCE PROGRAMME/1
CONFERENCE PROGRAMME/1 11:00 13:00 Workshop - room 3 building Z1 (entrance by the building Z) 13:00 14:45 Registration - CKU 13:30 14:30 Lunch - CKU 14:45 15:00 Opening of the Conference - CKU Plenary
More informationCancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi
Cancer SBL101 James Gomes School of Biological Sciences Indian Institute of Technology Delhi All Figures in this Lecture are taken from 1. Molecular biology of the cell / Bruce Alberts et al., 5th ed.
More informationMOTION FOR THE RESOLUTION BY THE COMMITTEE ON USING EMBRYONIC STEM CELLS
Wrocław, September 2010 MOTION FOR THE RESOLUTION BY THE COMMITTEE ON USING EMBRYONIC STEM CELLS The use of embryonic stem cells: Blessing or Curse? What are the opportunities and threats of this technology?
More informationInternational Scientific Conference
International Scientific Conference Under the Patronage of Minister of Sport and Turism Andrzej Biernat Silesian Voivode Piotr Litwa Major of Katowice Piotr Uszok His Magnificence, Rector of Jerzy Kukuczka
More informationFee-for-service cores for Investigational New Drug enabling studies
UC DAVIS INSTITUTE FOR REGENERATIVE CURES Fee-for-service cores for Investigational New Drug enabling studies Pipeline pathway at UC Davis Institute for Regenerative Cures Basic Research Proof of Concept
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More informationStem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine
Stem Cells and Inner Ear Cell Regeneration Stefan Heller Stanford University School of Medicine Embryonic stem cells Induced pluripotent stem cells Somatic stem cells 50 µm Derived from the inner cell
More information2nd BALTIC STEM CELL MEETING
2nd BALTIC STEM CELL MEETING 31st May 2nd June 2013 Szczecin, Poland GENERAL INFORMATION Organized by: POMERANIAN MEDICAL UNIVERSITY IN SZCZECIN In collaboration with: JAGIELLONIAN UNIVERSITY IN KRAKOW
More informationUpdate on Clinical Trials and Foundation Funded Grants
Update on Clinical Trials and Foundation Funded Grants Mary Hesdorffer, MS, APRN-BC Medical Liaison Meso Foundation www.curemeso.org Delivering the Diagnosis Delivering the Diagnosis Day 1 Taking control
More information63 Grzybowska St., Warsaw, Poland CONFERENCE PROGRAMME. Plenary session 1: The Education of Future Generations
Educational Conference The Qualifications System A Development Tool for Poland and Europe Wednesday, 6 November 2013, Hilton Hotel, Warsaw Hall II+III 63 Grzybowska St., Warsaw, Poland CONFERENCE PROGRAMME
More informationCNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010
CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 Organisers S. Gail Eckhardt, University of Colorado Denver, Aurora, USA Roy S. Herbst, The University of Texas MD Anderson
More informationConference: Photography among the Humanities National Library, December 12-13 2013
Conference: Photography among the Humanities National Library, December 12-13 2013 Program Thursday, December 12 2013 National Library in Warsaw 8.00 8.30 Registration 8.30 8.40 Welcome: Dr Tomasz Makowski
More informationScientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
More informationCourse Coordinators. 4-Year MD Program. 1 st year
4-Year MD Program Course Coordinators 1 st year Behavioral Sciences Department of Old Age Psychiatry & Psychotic Disorders Head of Department: Prof. Iwona Kłoszewska MD, PhD Coordinator: Marcin Flirski
More informationAGH - ZEISS Workshop on Focused Ion Beam techniques. Kraków, 9-10.06.2009
AGH - ZEISS Workshop on Focused Ion Beam techniques Kraków, 9-10.06.2009 AGH University of Science and Technology Faculty of Metal Engineering and Industrial Computer Science Al. Mickiewicza 30, 30-059
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More information58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement
SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA ABSTRACT DEADLINE May 2, 2016 First Announcement Scientific Coordinators Davide Melisi (Verona) Giampaolo Tortora (Verona) Local Scientific Committee Vincenzo
More information2 nd International Scientific and Training Conference International Day of Physiotherapy
40th Anniversary of Faculty of Health Sciences Poznan University of Medical Sciences 2 nd International Scientific and Training Conference International Day of Physiotherapy June 26-27, 2015r. Dear Colleagues
More information63 Grzybowska St., Warsaw, Poland DRAFT PROGRAMME. Michał Federowicz PhD, Director, Educational Research Institute
Educational Conference The Qualifications System A Development Tool for Poland and Europe Wednesday, 6 November 2013, Hilton Hotel, Warsaw Hall II+III 63 Grzybowska St., Warsaw, Poland DRAFT PROGRAMME
More information2nd BALTIC STEM CELL MEETING
2nd BALTIC STEM CELL MEETING 31st May 2nd June 2013 Szczecin, Poland GENERAL INFORMATION Organized by: POMERANIAN MEDICAL UNIVERSITY IN SZCZECIN In collaboration with: JAGIELLONIAN UNIVERSITY IN KRAKOW
More informationSupport structure for genetic material
Support structure for genetic material 1 Making proteins in the RER Making copies of humans 2 Making copies of cells Making copies of genetic material 3 Making copies of genetic material Making copies
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationCytotoxic and Biotherapies Credentialing Programme Module 2
Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal
More informationInternational Scientific Conference Identity and stereotypes Jews and Poles October 4, 2012 r. Jan Długosz Univeristy in Czestochowa
INVITATION International Scientific Conference Identity and stereotypes Jews and Poles October 4, 2012 r. Jan Długosz Univeristy in Czestochowa Organizer: Institute of Political Sciences Jan Dlugosz The
More informationColorectal Cancer Treatment
Scan for mobile link. Colorectal Cancer Treatment Colorectal cancer overview Colorectal cancer, also called large bowel cancer, is the term used to describe malignant tumors found in the colon and rectum.
More informationNew strategies in anticancer therapy
癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive
More informationExelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference
Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Two New Clinical Programs and Significant Expansion of Cancer Pipeline Planned for 2004 SOUTH SAN FRANCISCO, Calif., Jan. 13 /PRNewswire-FirstCall/
More informationOutline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice
Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment Radiation Biology Outline Introduction: Predictive assays in radiation therapy Examples for specific tumors Immunotherapy Summary
More informationLauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
More informationHow To Follow Up After Treatment With Gene Therapy
European Medicines Agency London, 30 May 2008 Doc. Ref. EMEA/CHMP/GTWP/60436/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON FOLLOW-UP OF PATIENTS ADMINISTERED WITH GENE THERAPY
More informationFuture Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
More informationAchievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for
Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its
More informationSpecial Guest of the Congress. Changes in economic environment as an opportunity to improve competitiveness of listed companies
ORGANIZER 8 8 Changes in economic environment as an opportunity to improve competitiveness of listed companies Special Guest of the Congress Włodzimierz Karpiński, Minister of Treasury 17 th -18 th of
More informationThe Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire
The Biological Basis of Cancer Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire Aim of Presentation By the end of this presentation you will: Be
More informationLibrary in the educational area. Librarian 2.0 modernity based on the tradition
23th May (Thursday) Library in the educational area. Librarian 2.0 modernity based on the tradition 8.00 9.00 Registration of participants. 23-24 May 2013 Conference program 9.00 9.30 Opening of the conference,
More informationSupport Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
More informationFACULTY OF MEDICAL SCIENCE
Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern
More informationHigh Grade Gliomas: Update in Treatment and Care Ryan T. Merrell, M.D. Clinical Assistant Professor of Neurology NorthShore University HealthSystem
High Grade Gliomas: Update in Treatment and Care Ryan T. Merrell, M.D. Clinical Assistant Professor of Neurology NorthShore University HealthSystem rmerrell@northshore.org Objectives Provide updates on
More informationCancer: DNA Synthesis, Mitosis, and Meiosis
Chapter 5 Cancer: DNA Synthesis, Mitosis, and Meiosis Copyright 2007 Pearson Copyright Prentice Hall, 2007 Inc. Pearson Prentice Hall, Inc. 1 What Is Cancer? Benign tumors do not invade surrounding tissue
More informationSTATISTICS AND CLINICAL PRACTICE
139 th ICB SEMINAR Ninth International Seminar on STATISTICS AND CLINICAL PRACTICE Chairmen: Prof. Leon Bobrowski Prof. Ulrich Mansmann Dr. Cornelia Enăchescu WARSAW, June 1 4, 2014 PROGRAMME OF THE SEMINAR
More informationThe ethics of stem cell research and treatment
The ethics of stem cell research and treatment Bernard Lo, M.D. March 12, 2009 1 hesc: ethical controversies Moral status of embryo? Clearly a potential person Some believe a person with rights Is hesc
More informationProton Therapy: Cutting Edge Treatment for Cancerous Tumors. By: Cherilyn G. Murer, JD, CRA
Proton Therapy: Cutting Edge Treatment for Cancerous Tumors By: Cherilyn G. Murer, JD, CRA Introduction Put simply, proton therapy is a new cutting edge cancer treatment that promises better outcomes for
More informationSenyo Agbenowu M.S Student Email: senyagbe@pharmacy.isu.edu Advisor: Dr. Daniels My research interest is studying the role of histone deacetylases
Senyo Agbenowu M.S Student Email: senyagbe@pharmacy.isu.edu Advisor: Dr. Daniels My research interest is studying the role of histone deacetylases (HDAC) in Dexamethasone resistance in Interleukin 6 (IL6)
More informationINSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific
More informationChapter 8. Summary and Perspectives
Chapter 8 Summary and Perspectives 131 Chapter 8 Summary Overexpression of the multidrug resistance protein MRP1 confer multidrug resistance (MDR) to cancer cells. The contents of this thesis describe
More informationMATHEMATICAL ONCOLOGY: NEW CHALLENGES FOR SYSTEMS BIOMEDICINE
International Centre for Scientific Culture E. Majorana" School of Mathematics G. Stampacchia MATHEMATICAL ONCOLOGY: NEW CHALLENGES FOR SYSTEMS BIOMEDICINE September 26-30, 2011 Program of Lectures Monday
More informationROOM B 16.00-18.00 OPENING CEREMONY
17 th September 2015 16.00-18.00 OPENING CEREMONY Introduction President of the Polish Pharmacological Society professor Marek Droździk Lecture in progress 50 years of the Polish Pharmacological Society
More informationCancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.
Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationHow To Change Medicine
P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version
More informationInternational Symposium on Malignant Mesothelioma 2011 -- curemeso.org
Measles virotherapy for malignant mesothelioma Manish R. Patel, D.O. Assistant Professor of Medicine University of Minnesota June 25, 2011 Medical Treatment of Mesothelioma Majority of patients are not
More informationMyeloid Leukemias - Current and Future Approaches to Targeted and Individualized Therapies
Myeloid Leukemias - Current and Future Approaches to Targeted and Individualized Therapies Robert J. Arceci, M.D., Ph.D. King Fahd Professor of Pediatric Oncology Professor of Pediatrics, Oncology and
More informationContact Information Korea Health Industry Development Institute
AGM-130, a novel CDK inhibitor with a marked anti-tumor activity and reduced toxicity, targeting the triple negative breast cancer(tnbc) and tamoxifen-resistant estrogen receptor (ER) positive breast cancer
More informationGriffith University - Case for Support. Mesothelioma Research Program
Griffith University - Case for Support Mesothelioma Research Program Professor Lyn Griffiths Director, Dean, Research and Director, Genomics Research Centre (GHI) Established in 2007. Integrated health
More informationClinical Cancer Research: Alternative IRB Models and Enhancing Progress
Clinical Cancer Research: Alternative IRB Models and Enhancing Progress Lowell E. Schnipper, M.D. Berenson Professor of Medicine Chief, Hematology-Oncology Beth Israel Deaconess Medical Dynamics of Clinical
More information5 th CENTRAL EUROPEAN CONGRESS ON OSTEOPOROSIS AND OSTEOARTHRITIS
5 th CENTRAL EUROPEAN CONGRESS ON OSTEOPOROSIS AND OSTEOARTHRITIS 17 th CONGRESS OF THE POLISH OSTEOARTHROLOGY SOCIETY AND POLISH FOUNDATION OF OSTEOPOROSIS Krakow, 20-21 September 2013 2nd ANNOUNCEMENT
More informationAnswer Key. Vocabulary Practice
Answer Key Vocabulary Practice Copyright by McDougal Littell, a division of Houghton Mifflin Company A. Categorize Words 1. organism, L; cell, L; species, L; transgenic, B; biotechnology, T; molecular
More informationLEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational
More informationPublic-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics
EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC
More informationRADIATION THERAPY FOR LYMPHOMA. Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY
RADIATION THERAPY FOR Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT The lymphatic system is a network of tiny vessels extending
More informationHospice care for children in Poland - achievements, challenges and perspectives
An announcement no 1 of the International Scientific Conference on the 10th anniversary of the Malopolska Hospice for Children Dear Sir/Madam, Hospice care for children is a socially important issue that
More informationUnderstanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient
Understanding series LUNG CANCER: new treatment directions 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS What s New in lung cancer? Advancements...4 Changes in genes that
More informationThe following information is only meant for people who have been diagnosed with advanced non-small cell
Important information for people with advanced non-small cell lung cancer The following information is only meant for people who have been diagnosed with advanced non-small cell lung cancer (NSCLC). NSCLC
More informationBIOSKETCH. Degrees: Cand. real. 1971, Dr. philos. 1978. University of Bergen, Norway
BIOSKETCH Johan R. Lillehaug Born: 25.09.45 Home address: Ibsensgate 89, 5052 Bergen Nationality: Norwegian Present position: Department Chairman (2004- ) and Professor in biotechnology (1987-), Department
More informationAdvances in Biology and Treatment of Malignant Brain Gliomas
Advances in Biology and Treatment of Malignant Brain Gliomas International Congress 2 nd Edition Rome, June 12-13, 2014 President Giulio Maira Vice Presidents Ruggero De Maria, Antonio Iavarone, Angelo
More informationMultiple Myeloma (Event Driven)
Brochure More information from http://www.researchandmarkets.com/reports/2234830/ Multiple Myeloma (Event Driven) Description: The 2010 multiple myeloma (myeloma) market garnered impressive sales despite
More informationWhat s New in Ovarian Cancer Research? Novel Therapeutics for Ovarian Cancer
What s New in Ovarian Cancer Research? Novel Therapeutics for Ovarian Cancer Scott Kaufmann, M.D., Ph.D. Mayo Clinic Division of Oncology Research October 27, 2012 Where we are now. Surgery Front-line
More informationOne out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3
1. What is cancer? 2. What causes cancer?. What causes cancer? 3. Can cancer be prevented? The Facts One out of every two men and one out of every three women will have some type of cancer at some point
More informationCancer Gene Therapy: Challenges and Opportunities
ANTICANCER RESEARCH 24: xxx-xxx (2004) No: 4643-S Please mark the appropriate section for this paper Experimental Clinical Epidemiological Review Cancer Gene Therapy: Challenges and Opportunities KEVIN
More informationHouston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
More informationFederal Funding for Technological Revolutions: Biotechnology and Healthcare Highlights
ADVANCED TE CHNOLOGY P ROGRAM The Advanced Technology Program Federal Funding for Technological Revolutions: Biotechnology and Healthcare Highlights April 2006 National Institute of Standards and Technology
More informationMédecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN
Médecine de précision médecine personnalisée en Oncologie Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Successful targeted drug development Rapid identification
More informationCreating a cgmp Facility for Early Clinical Trials of Molecular Imaging and Therapeutic Agents
Designing for the Frontiers of Research Creating a cgmp Facility for Early Clinical Trials of Molecular Imaging and Therapeutic Agents Richard J. Mohr What if it were possible to treat a cancer patient
More informationThe International Center of Hearing and Speech is equipped with modern devices for distance learning of specialists. There is 3D teletransmission
The International Center of Hearing and Speech is equipped with modern devices for distance learning of specialists. There is 3D teletransmission from the surgical theatre to the conference room and/or
More informationScientific Conference HQ FORUM Quality forum in healthcare
Scientific Conference HQ FORUM Quality forum in healthcare Poland - Gdansk 24-25.09.2014 Conference Patronage: Rector of the Gdansk University of Technology prof. dr hab. inż. Henryk Krawczyk - Rector
More informationA Letter from MabVax Therapeutics President and Chief Executive Officer
A Letter from MabVax Therapeutics President and Chief Executive Officer Dear Fellow Stockholder: You have invested in MabVax Therapeutics because you share our passion for finding new therapies for the
More informationGene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press
Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction
More informationbringing fun and interesting facts about the csuci biology program to you! 4th edition - spring 2009
SEE WHAT S UNDER THE SCOPE PAGE 5 bringing fun and interesting facts about the csuci biology program to you! 4th edition - spring 2009 This year our 5th Annual Poe Symposium was held on May 1. The title
More informationAnforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research
Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from
More informationAnti-angiogenesis Treatment
Anti-angiogenesis Treatment The search for better cancer drugs Today we are better able to treat cancer than ever. More than half of all people with cancer now live at least 5 years after being diagnosed.
More informationTHE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
More informationMidwinter Conference 2015 January 17-22 Seefeld, Tyrol CONFERENCE PROGRAM. midwinter2015.org. Sponsored by
Midwinter Conference 2015 January 17-22 Seefeld, Tyrol CONFERENCE PROGRAM Sponsored by SATURDAY, 17 January 18.00-19.00 Keynote lecture Richard Flavell Sponsored by 19.00 Welcome Reception Hosted by SUNDAY,
More informationInternational Stem Cell Registry
International Stem Cell Registry Importance of Stem Cells Stem cells are model systems for the study of development and disease. Pluripotent stem cells offer new tools for drug design and discovery. Pluripotent
More informationפוגרומים POGROMS ПОГРОМЫ POGROME
POGROMY ŻIH פוגרומים POGROMS ПОГРОМЫ POGROME פאגראמען INTERNATIONAL ACADEMIC CONFERENCE POGROMS: COLLECTIVE ANTI-JEWISH VIOLENCE IN THE POLISH LANDS IN THE 19TH AND 20TH CENTURIES PROGRAM Pogroms: Collective
More information